Once-Weekly Dulaglutide with Insulin Therapy for Type 2 Diabetes: Efficacy and Safety Results from a Phase 4, Randomized, Placebo-Controlled Study

INTRODUCTION: Although global studies have investigated the combination of dulaglutide with insulin in patients with type 2 diabetes mellitus (T2DM), differences in lean body mass and dulaglutide dosing can complicate the extrapolation of global study results to Japanese patients. This phase 4, rand...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Diabetes Ther
Hlavní autoři: Ishii, Hitoshi, Onishi, Yukiko, Oura, Tomonori, Takeuchi, Masakazu
Médium: Artigo
Jazyk:Inglês
Vydáno: Springer Healthcare 2019
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6965529/
https://ncbi.nlm.nih.gov/pubmed/31758520
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-019-00726-8
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky